Abstract
Giant cell tumor of soft tissue with low malignant potential (GCT-ST) is a low-grade, primary soft tissue sarcoma with histological and clinical features similar to giant cell tumor of the bone. The main tumor localizations are the extremities, but it may also occur in the head and neck region. GCT-ST shows a recurrence rate of approximately 15%, but it very rarely metastasizes. The risk of cancer development, especially of the skin, is up to fivefold increased in immunosuppressed patients after organ transplantation. The association of sarcomas and immunosuppressive therapy is best known for Kaposi sarcomas, whereas other types of sarcomas are rarely found. We report of a GCT-ST of low malignant potential, which developed under long-term immunosuppression in a patient 12 years after heart transplantation. The tumor presented with an unusual aggressive course and metastatic site: the parotid gland. Therefore, we suggest that in patients with immunosuppression, even low malignant cancerous lesions should be carefully observed, as their local behavior may be aggressive with development of metastasis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aleman Lopez O, Carreno VM, Duran R, Garcia-Ortega F, Bonnin OJ, Malluguiza CR (1999) Parotid metastasis of liposarcoma of the lower limbs. Acta Otorrinolaringol Esp 50:667–670
Dantal J, Soulillou JP (2005) Immunosuppressive drugs and the risk of cancer after organ transplantation. N Engl J Med 352:1371–1373
Euvrard S, Kanitakis J, Claudy A (2003) Skin cancers after organ transplantation. N Engl J Med 348:1681–1691
Folpe AL, Morris RJ, Weiss SW (1999) Soft tissue giant cell tumor of low malignant potential: a proposal for the reclassification of malignant giant cell tumor of soft parts. Mod Pathol 12:894–902
Gourin CG, Terris DJ (2004) Head and neck cancer in transplant recipients. Curr Opin Otolaryngol Head Neck Surg 12:122–126
Hoshida Y, Aozasa K (2004) Malignancies in organ transplant recipients. Pathol Int 54:649–658
Lee ES, Locker J, Nalesnik M, Reyes J, Jaffe R, Alashari M, Nour B, Tzakis A, Dickman PS (1995) The association of Epstein–Barr virus with smooth-muscle tumors occurring after organ transplantation. N Engl J Med 332:19–25
Moosa MR (2005) Kaposi’s sarcoma in kidney transplant recipients: a 23-year experience. QJM 98:205–214
Nascimento AG (2002) Giant cell tumor of soft tissue. In: Fletcher CDM, Unni KK, Mertens F (eds) World Health Organization classification of tumours. Pathology and genetics of tumours of soft tissue and bone. IARC Press, Lyon, pp 118–119
O’Connell JX, Wehrli BM, Nielsen GP, Rosenberg AE (2000) Giant cell tumors of soft tissue: a clinicopathologic study of 18 benign and malignant tumors. Am J Surg Pathol 24:386–395
Oliveira AM, Dei Tos AP, Fletcher CD, Nascimento AG (2000) Primary giant cell tumor of soft tissues: a study of 22 cases. Am J Surg Pathol 24:248–256
Penn I (1994) Depressed immunity and the development of cancer. Cancer Detect Prev 18:241–252
Penn I (2000) Post-transplant malignancy: the role of immunosuppression. Drug Saf 23:101–113
Saiz AD, Sachdev U, Brodman ML, Deligdisch L (1998) Metastatic uterine leiomyosarcoma presenting as a primary sarcoma of the parotid gland. Obstet Gynecol 92:667–668
Traywick C, O’Reilly FM (2005) Management of skin cancer in solid organ transplant recipients. Dermatol Ther 18:12–18
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Grabellus, F., von Winterfeld, F., Sheu, SY. et al. Unusual aggressive course of a giant cell tumor of soft tissue during immunosuppressive therapy. Virchows Arch 448, 847–851 (2006). https://doi.org/10.1007/s00428-006-0184-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00428-006-0184-7